Literature DB >> 3910167

Vasopressin-induced motor disturbances: localization of a sensitive forebrain site in the rat.

A M Naylor, W D Ruwe, D M Burnard, P D McNeely, S L Turner, Q J Pittman, W L Veale.   

Abstract

Arginine-vasopressin (AVP) microinjected into an area extending from the diagonal band of Broca to the anterior hypothalamus of the rat evokes severe motor disturbances, including barrel rotations and myoclonic/myotonic movements. These disturbances do not occur after administration of an artificial physiological solution or of oxytocin. Injection of this peptide into other areas of the brain does not cause these effects. This action of vasopressin is dose-related, can be prevented by the prior administration of an AVP receptor antagonist and involves a 'sensitization' process. It is possible that AVP, acting in this mediobasal region of the forebrain, might be involved as a causative agent in some convulsive disorders.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3910167     DOI: 10.1016/0006-8993(85)91295-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Evidence supporting a role for endogenous vasopressin in fever suppression in the rat.

Authors:  K E Cooper; A M Naylor; W L Veale
Journal:  J Physiol       Date:  1987-06       Impact factor: 5.182

2.  Alteration of the physiological responses to indomethacin by endotoxin tolerance in the rat: a possible role for central vasopressin.

Authors:  M F Wilkinson; Q J Pittman
Journal:  J Physiol       Date:  1994-09-15       Impact factor: 5.182

3.  Sodium salicylate: alternate mechanism of central antipyretic action in the rat.

Authors:  S J Alexander; K E Cooper; W L Veale
Journal:  Pflugers Arch       Date:  1989-03       Impact factor: 3.657

4.  Brain volume increase and neuronal plasticity underly predator-induced morphological defense expression in Daphnia longicephala.

Authors:  A Graeve; I Ioannidou; J Reinhard; D M Görl; A Faissner; L C Weiss
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.